We are live on
!
Find out more
HTHT
Hemenway Trust Hemenway Trust Portfolio holdings
AUM
$1.24B
1-Year Est. Return
16.47%
This Fund
S&P 500
This Quarter
Est. Return
+2.58%
1 Year Est. Return
+16.47%
3 Year Est. Return
+58.43%
5 Year Est. Return
+76.48%
10 Year Est. Return
+293.52%
AUM
$318M
AUM Growth
+$5.84M
(+1.9%)
Cap. Flow
+$2.39M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.09%
Holding
189
New
13
Increased
51
Reduced
35
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$197K |
| 2 |
Sasol
SSL
|
+$196K |
| 3 |
Procter & Gamble
PG
|
+$191K |
| 4 |
Equinor
EQNR
|
+$191K |
| 5 |
Johnson & Johnson
JNJ
|
+$167K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$929K |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
+$808K |
| 3 |
Stryker
SYK
|
+$271K |
| 4 |
PepsiCo
PEP
|
+$262K |
| 5 |
CEO
CNOOC Limited
CEO
|
+$221K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 20% |
| 3 | Industrials | 12.98% |
| 4 | Energy | 12.32% |
| 5 | Consumer Staples | 8.48% |
Similar funds
BCP
SPC
CCA
FFM
ODIJL
LMGAM
LIA
TCA
Hemenway Trust Hemenway Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Hemenway Trust Hemenway Trust held 189 positions worth $318M, up 1.9% from $312M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Hemenway Trust Hemenway Trust's Q1 2014 filing shows 13 new, 51 increased, 35 reduced and 5 closed positions. Its largest new stake was Vanguard Real Estate ETF: 2,871 shares worth $203K. The largest sale was Alnylam Pharmaceuticals, an estimated $929K.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Hemenway Trust Hemenway Trust's largest Q1 2014 buy was Vanguard Real Estate ETF: 2,871 shares worth $203K.
- Hemenway Trust Hemenway Trust added most to Procter & Gamble in Q1 2014, an estimated $191K increase.
- Hemenway Trust Hemenway Trust's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $929K.
- Hemenway Trust Hemenway Trust fully exited Stryker in Q1 2014, selling an estimated $271K.
- Hemenway Trust Hemenway Trust's ten largest holdings make up 28% of its $318M portfolio in Q1 2014.
- Hemenway Trust Hemenway Trust opened 13 new positions and closed 5 in Q1 2014.
- Hemenway Trust Hemenway Trust's portfolio value rose 1.9% quarter-over-quarter to $318M.
Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2014, filed 23 May 2014.